Control Bionics Limited (CBL.AX)
AUD 0.04
(-12.77%)
AUD 0.04
(-12.77%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 2.75 Million AUD | 78.2% |
| 2023 | 1.54 Million AUD | 2.39% |
| 2022 | 1.51 Million AUD | 27.07% |
| 2021 | 1.19 Million AUD | 207.54% |
| 2020 | 387 Thousand AUD | 2.98% |
| 2019 | 375.79 Thousand AUD | 74.08% |
| 2018 | 215.88 Thousand AUD | -99.98% |
| 2017 | 911.3 Million NZD | 65.61% |
| 2016 | 550.26 Million NZD | 18.64% |
| 2015 | 463.79 Million NZD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 2.75 Million AUD | 125.9% |
| 2024 Q2 | 1.22 Million AUD | 0.0% |
| 2024 Q4 | 2.75 Million AUD | 0.0% |
| 2024 FY | 2.75 Million AUD | 78.2% |
| 2024 Q1 | 1.22 Million AUD | -21.11% |
| 2023 Q2 | 1.32 Million AUD | 0.0% |
| 2023 Q4 | 1.54 Million AUD | 1.02% |
| 2023 FY | 1.54 Million AUD | 2.39% |
| 2023 Q3 | 1.53 Million AUD | 15.74% |
| 2023 Q1 | 1.32 Million AUD | -12.42% |
| 2022 FY | 1.51 Million AUD | 27.07% |
| 2022 Q4 | 1.51 Million AUD | 0.0% |
| 2022 Q3 | 1.51 Million AUD | -8.14% |
| 2022 Q2 | 1.64 Million AUD | 0.0% |
| 2022 Q1 | 1.64 Million AUD | 38.32% |
| 2021 Q1 | - AUD | -100.0% |
| 2021 FY | 1.19 Million AUD | 207.54% |
| 2021 Q4 | 1.19 Million AUD | 1.44% |
| 2021 Q3 | 1.17 Million AUD | 49.9% |
| 2021 Q2 | 782.77 Thousand AUD | 0.0% |
| 2020 Q4 | 622.4 Thousand AUD | 0.0% |
| 2020 FY | 387 Thousand AUD | 2.98% |
| 2019 FY | 375.79 Thousand AUD | 74.08% |
| 2018 FY | 215.88 Thousand AUD | -99.98% |
| 2017 FY | 911.3 Million NZD | 65.61% |
| 2017 Q2 | 911.3 Million NZD | 0.0% |
| 2016 FY | 550.26 Million NZD | 18.64% |
| 2015 FY | 463.79 Million NZD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| 4DMedical Limited | 49.08 Million AUD | 94.378% |
| Adherium Limited | 3.4 Million AUD | 18.996% |
| Aroa Biosurgery Limited | 14.77 Million AUD | 81.327% |
| Atomo Diagnostics Limited | 1.29 Million AUD | -113.197% |
| Anteris Technologies Ltd | 17.03 Million AUD | 83.804% |
| CardieX Limited | 8.56 Million AUD | 67.77% |
| Compumedics Limited | 22.14 Million AUD | 87.54% |
| Cochlear Limited | 904.6 Million AUD | 99.695% |
| CleanSpace Holdings Limited | 6.94 Million AUD | 60.292% |
| Cyclopharm Limited | 13.65 Million AUD | 79.79% |
| EMVision Medical Devices Ltd | 5.45 Million AUD | 49.418% |
| Nova Eye Medical Limited | 8.55 Million AUD | 67.732% |
| HeraMED Limited | 1.5 Million AUD | -83.248% |
| Imricor Medical Systems, Inc. | 25 Million AUD | 88.963% |
| ImpediMed Limited | 6.24 Million AUD | 55.797% |
| InhaleRx Limited | 911.41 Thousand AUD | -202.783% |
| LBT Innovations Limited | 5.5 Million AUD | 49.898% |
| Micro-X Limited | 12.63 Million AUD | 78.157% |
| Neurotech International Limited | 314.69 Thousand AUD | -776.902% |
| OncoSil Medical Limited | 1.98 Million AUD | -39.234% |
| PolyNovo Limited | 37.04 Million AUD | 92.55% |
| Respiri Limited | 3.55 Million AUD | 22.352% |
| SomnoMed Limited | 24.78 Million AUD | 88.864% |
| Universal Biosensors, Inc. | 10.61 Million AUD | 73.997% |
| Uscom Limited | 2.07 Million AUD | -33.084% |
| Visioneering Technologies, Inc. | 2.76 Million AUD | 0.264% |